These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2098310)

  • 1. Secondary prophylaxis with antiarrhythmic agents in survivors of myocardial infarction.
    Sethi KK; Mohan JC
    Indian Heart J; 1990; 42(6):403-5. PubMed ID: 2098310
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of anti-arrhythmia therapy on mortality of patients after myo cardial infarction].
    Opolski G; Dabrowski R
    Pol Tyg Lek; 1993 Jan 18-25; 48(3-4):91-3. PubMed ID: 8361899
    [No Abstract]   [Full Text] [Related]  

  • 3. Amiodarone in high-risk post-infarction patients, Lessons from EMIAT and CAMIAT. European Myocardial Infarct Amiodarone Trial and Canadian Amiodarone Myocardial Infarction Arrhythmia Trial.
    Gambhir DS
    Indian Heart J; 1996; 48(4):339-41. PubMed ID: 8908817
    [No Abstract]   [Full Text] [Related]  

  • 4. Should antiarrhythmic drug prophylaxis be routine after acute myocardial infarction?
    Halkin H; Melmon KL
    Ration Drug Ther; 1973 Jun; 7(6):1-5. PubMed ID: 4731079
    [No Abstract]   [Full Text] [Related]  

  • 5. Should prophylactic antiarrhythmic drug therapy be employed in acute myocardial infarction?
    Berte LE; Harrison DC
    Cardiovasc Clin; 1983; 13(1):173-81. PubMed ID: 6336666
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiarrhythmic therapy in post myocardial infarction patients.
    Cowan C; Campbell RW
    Eur Heart J; 1986 May; 7 Suppl A():145-7. PubMed ID: 3720769
    [No Abstract]   [Full Text] [Related]  

  • 7. [Secondary prevention in the post-infarction period].
    Corea L; Bentivoglio M
    Cardiologia; 1989 Feb; 34(2):127-33. PubMed ID: 2567624
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical evaluation of the anti-arrhythmic properties and cardiohemodynamic effects of the basic anti-arrhythmia agents].
    Stoliarchuk AA; Storozhuk BG; Briskin VR
    Farmakol Toksikol; 1985; 48(1):5-10. PubMed ID: 3979536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ventricular cardiac arrhythmias. New anti-arrhythmia agents].
    Scholz H
    Z Kardiol; 1996; 85 Suppl 6():91-6. PubMed ID: 9064988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment after acute myocardial infarction: antiarrhythmic therapy and prophylaxis. Which drug for which patient?
    Bracchetti D; Naccarella F; Palmieri M; Fulvi M; Pavesi PC
    J Cardiovasc Pharmacol; 1989; 14 Suppl 9():S79-83. PubMed ID: 2483239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic therapy in the post-infarction setting: update from major amiodarone studies.
    Cairns JA
    Int J Clin Pract; 1998 Sep; 52(6):422-4. PubMed ID: 9894381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic strategies in acute myocardial infarction: antiarrhythmic therapy].
    Le Heuzey JY; Copie X; Iliou MC; Guize L
    Arch Mal Coeur Vaiss; 1998 Apr; 91 Spec No 2():39-42. PubMed ID: 9749275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Stratification of arrhythmia risk and therapeutic options in survivors of acute myocardial infarction].
    Arós Borau F; Loma-Osorio A; Torres Bosco A
    Rev Esp Cardiol; 1996 Mar; 49(3):157-65. PubMed ID: 8685518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiarrhythmic effects of stirocainide in acute myocardial infarction.
    Gülker H; Bender F; Thale J; Heuer H; Kristek J; Hübner G; Dorsel T; Schmidt J
    Arzneimittelforschung; 1984; 34(5):559-62. PubMed ID: 6540572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiarrhythmic therapy: reminders from CAST.
    Hasegawa GR
    Clin Pharm; 1989 Jul; 8(7):509. PubMed ID: 2752701
    [No Abstract]   [Full Text] [Related]  

  • 16. Indications for antiarrhythmic therapy as prophylaxis against sudden death.
    Peter T; Hamamoto H; Jordon J; Platt M; Mandel W
    Cardiovasc Clin; 1980; 11(1):249-66. PubMed ID: 7002303
    [No Abstract]   [Full Text] [Related]  

  • 17. [Arrhythmia as risk factor].
    Internist (Berl); 1997 Feb; 38(2 Suppl Risikofakt):1-8. PubMed ID: 9330651
    [No Abstract]   [Full Text] [Related]  

  • 18. [Secondary prevention after myocardial infarction].
    Czuriga I
    Orv Hetil; 2002 Sep; 143(37):2117-28. PubMed ID: 12434627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic therapy for the prevention of sudden cardiac death.
    Cairns J; Kerr C; Teo K
    Can J Cardiol; 2000 Jun; 16 Suppl C():29C-33C. PubMed ID: 10887276
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiarrhythmic drug prescription in patients after myocardial infarction in the last decade. Experience of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI).
    Avanzini F; Latini R; Maggioni A; Colombo F; Santoro E; Franzosi MG; Tognoni G
    Arch Intern Med; 1995 May; 155(10):1041-5. PubMed ID: 7748046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.